Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications
Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited
From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...
Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data
Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited
The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.
Unlimited wins at Communiqué Awards
Press Releases | July 11, 2016 | Health Unlimited
Health Unlimited, Liberation Unlimited and Rock Unlimited all win the judges’ approval.
Lucid Group shines at the Communiqué Awards
Press Releases | July 8, 2016 | Lucid Group Communications Limited
Lucid Group’s commitment to be a leader in medical education was recognised at the Communiqué Awards 2016 in London last night, where the agency received three awards, including being highly...
What have you learned about your customers recently?
White Papers and Resources | July 6, 2016 | Anthill Agency
Your customer-facing staff continually gets told about the needs and wants of your customers. Are you learning what they are learning?
Infographic: HIV Market Snapshot
White Papers and Resources | July 6, 2016 | Inizio
Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...
Infographic: The vaccine opportunity in Asia
White Papers and Resources | July 6, 2016 | Inizio
As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...
Webinar: What next for biosimilars?
White Papers and Resources | July 6, 2016 | Inizio
Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST
Understanding the Patient Journey
White Papers and Resources | July 6, 2016 | Inizio
The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme. Technology...
Case Study: Oncology diagnostic biomarker landscaping study
White Papers and Resources | July 6, 2016 | Inizio
The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...